Sanjiv Patel insider trades: Relay Therapeutics (RLAY) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Sanjiv reports to the SEC
Open-market buys and sales
17 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 7, 2026 | RLAY | ↓ Sell | 48,199 | $18.10 | $872K | Direct | Oct 8, 2026 (1d) |
| Jul 7, 2026 | RLAY | ↓ Sell | 48,199 | $19.58 | $944K | Direct | Jul 8, 2026 (1d) |
| Jan 6, 2026 | RLAY | ↓ Sell | 43,168 | $7.82 | $338K | Direct | Jan 7, 2026 (1d) |
| Nov 3, 2025 | RLAY | ↓ Sell | 62,073 | $7.00 | $435K | Direct | Nov 4, 2025 (1d) |
| Jul 9, 2025 | RLAY | ↓ Sell | 61,379 | $3.57 | $219K | Direct | Jul 10, 2025 (1d) |
| Apr 23, 2025 | RLAY | ↓ Sell | 61,422 | $2.97 | $182K | Direct | Apr 24, 2025 (1d) |
| Feb 13, 2025 | RLAY | ↓ Sell | 215,506 | $3.80 | $818K | Direct | Feb 13, 2025 (0d) |
| Jan 23, 2025 | RLAY | ↓ Sell10b5-1 | 375,000 | $4.70 | $1.8M | By The Patel Family Irrevocable Trust of | Jan 23, 2025 (0d) |
| Dec 16, 2024 | RLAY | ↓ Sell10b5-1 | 100,000 | $5.00 | $500K | By The Patel Family Irrevocable Trust of | Dec 18, 2024 (2d) |
| Jul 26, 2024 | RLAY | ↓ Sell | 86,706 | $9.12 | $791K | Direct | Jul 29, 2024 (3d) |
| Feb 9, 2023 | RLAY | ↓ Sell | 42,000 | $20.99 | $882K | Direct | Feb 9, 2023 (0d) |
| Jan 19, 2023 | RLAY | ↓ Sell | 84,000 | $20.37 | $1.7M | Direct | Jan 19, 2023 (0d) |
| Nov 10, 2022 | RLAY | ↓ Sell | 42,000 | $20.06 | $843K | Direct | Nov 10, 2022 (0d) |
| Oct 13, 2022 | RLAY | ↓ Sell | 42,000 | $21.04 | $884K | Direct | Oct 13, 2022 (0d) |
| Sep 15, 2022 | RLAY | ↓ Sell | 42,000 | $24.24 | $1.0M | Direct | Sep 15, 2022 (0d) |
| Apr 14, 2022 | RLAY | ↓ Sell | 70,000 | $31.60 | $2.2M | Direct | Apr 14, 2022 (0d) |
| Jul 20, 2020 | RLAY | ↑ Buy | 25,000 | $20.00 | $500K | Direct | Jul 21, 2020 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other RLAY insiders
Open-market trades in the last 12 months
About Sanjiv Patel's insider trades
Sanjiv Patel is President and CEO at Relay Therapeutics (RLAY). Since Jul 20, 2020, Sanjiv has reported 1 open-market purchase worth $500K and 16 sales worth $14.4M on SEC Form 4. In the last 12 months: 3 sales ($2.2M).
2 sales (16% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (17 filings), option exercises (7 filings), gifts (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RLAY insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.